BLFS - BIOLIFE SOLUTIONS INC
IEX Last Trade
26.47
-0.030 -0.113%
Share volume: 0
Last Updated: Thu 26 Dec 2024 03:30:01 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$26.50
-0.03
-0.11%
Fundamental analysis
17%
Profitability
0%
Dept financing
13%
Liquidity
75%
Performance
20%
Performance
5 Days
-3.25%
1 Month
-1.01%
3 Months
10.51%
6 Months
24.06%
1 Year
65.32%
2 Year
50.06%
Key data
Stock price
$26.47
DAY RANGE
N/A - N/A
52 WEEK RANGE
$15.86 - $28.88
52 WEEK CHANGE
$57.18
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Michael P. Rice
Region: US
Website: biolifesolutions.com
Employees: 440
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: biolifesolutions.com
Employees: 440
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for cell and gene therapy industry. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor.
Recent news